Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
The Medicine Maker
Antibody drug conjugates have been hailed as “magic bullets” for years. Are they finally about to live up to the hype? Experts in our cover feature discuss. Also in this issue; we speak with Lubrizol, which won an Innovation Award for itssolubility-enhancing excipient Apisolex; learn about oligonucleotides from CatSci’s Nigel Richardson; and find out why new approaches are needed for antimicrobial resistance. We also sit down with Tirtha Chakraborty from Vor Bio and take a look at the top prospects in the cell and gene sector.